News from the FDA/CDC

Nebulized LAMA for COPD approved

A long-acting muscarinic antagonist for COPD is now available in a nebulizer form in the United States.


FDA approves first therapy treatment for EGPA

Approval of using mepolizumab for EGPA was based on data from a 52-week clinical trial that compared it with placebo, according to the FDA.

Conference Coverage

VIDEO: Weight loss cut risk of breast cancer

SAN ANTONIO – Women in the Women’s Health Initiative Observational Study who lost at least 5% of their body weight had a significant 12% reduction...

From the Journals

Tc-325 effective for immediate GI tumor bleeding

This powder seems to be more predictably effective in providing initial hemostasis in upper GI tumor bleeding, compared with conventional methods...

From the Journals

Hyperbaric oxygen may cut CO deaths

Undergoing more hyperbaric oxygen sessions reduced the mortality rate in a study of patients with carbon monoxide poisoning.